Phio Pharmaceuticals Corp. (PHIO)
1.14
-0.02
(-1.72%)
USD |
NASDAQ |
Feb 19, 16:00
1.16
+0.02
(+1.75%)
Pre-Market: 08:30
Phio Pharmaceuticals EPS Diluted (Quarterly) : -0.4374 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.392M |
| Total Expenses (Quarterly) | 2.392M |
| Enterprise Value | 1.566M |
| Earnings Yield | -196.3% |
| Normalized Earnings Yield | -196.29 |